Journal Metrics

Acceptance rate

14%

Submission to final decision

36 days

Acceptance to publication

7 days

Scopus CiteScore

1.8

APC

$369

Journal of Advanced Biotechnology and Experimental Therapeutics

eISSN 2616-4760

Journal of Advanced Biotechnology and Experimental Therapeutics (JABET) – is an open-access, international, peer-reviewed, scientific journal publishing original research, reviews, editorials, short communications, and commentaries on all aspects of biotechnology and experimental therapeutics. It provides a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in translational research and recent discoveries in the biotechnology and biomedical sciences.

Original article

Exploring the role of autoantibodies in Iraqi females with polycystic ovary syndrome

Abdullah SalimAl-Karawi,

Ali SaadKadhim

J Adv Biotechnol Exp Ther. 2024; 7(1): 147-156|Doi: 10.5455/jabet.2024.d13
Original article

High-intensity interval training increases AMPK and GLUT4 expressions via FGF21 in skeletal muscles of diabetic rats

Neng TineKartinah,

HardiyantiRusli

...

JulfianaMardhatillah

J Adv Biotechnol Exp Ther. 2024; 7(1): 136-146|Doi: 10.5455/jabet.2024.d12
Original article

Human mesenchymal stem cell secretome lowers caspase-3 levels and apoptosis in hepatocytes of cholestatic rats

Naufal FaruqPurwanto,

NeniSusilaningsih

...

IgnatiusRiwanto

J Adv Biotechnol Exp Ther. 2024; 7(1): 44-52|Doi: 10.5455/jabet.2024.d04

Current Issue

SCImago Journal & Country Rank

Loading Twitter timeline...